XT
FLGT icon

XTX Topco’s Fulgent Genetics FLGT Stock Holding History

XTX Topco’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.47M Buy
92,499
+70,304
+317% +$1.53M 0.03% 1096
2025
Q4 		$583K Buy
22,195
+5,523
+33% +$143K 0.02% 1466
2025
Q3 		$377K Buy
16,672
+297
+2% +$6.12K 0.02% 1312
2025
Q2 		$326K Sell
16,375
-2,774
-14% -$54.1K 0.01% 1373
2025
Q1 		$324K Buy
+19,149
New +$326K 0.02% 1344
2022
Q3 		– Sell
-4,489
Closed -$245K – 1183
2022
Q2 		$245K Buy
+4,489
New +$247K 0.1% 367

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

XTX Topco's FLGT Position: Q1 2026 in Review

XTX Topco increased its Fulgent Genetics (FLGT) stake by 317% in Q1 2026, buying an estimated $1.53M and bringing the position to 92,499 shares worth $1.47M. The position accounts for 0.03% of the portfolio, ranked #1096.

XTX Topco first reported a position in FLGT in Q2 2022 and has held it in 6 quarters since. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • XTX Topco held 92,499 shares of Fulgent Genetics worth $1.47M as of Q1 2026.
  • XTX Topco bought 70,304 Fulgent Genetics shares in Q1 2026, an estimated $1.53M.
  • Fulgent Genetics made up 0.03% of XTX Topco's portfolio in Q1 2026, its #1096 holding.
  • XTX Topco first reported a position in Fulgent Genetics in Q2 2022 and has held it in 6 quarters since.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.